http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2264228-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f19b39ce06f57761648185027f1a1a96 |
| publicationDate | 2005-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2264228-C2 |
| titleOfInvention | Agent used in prophylaxis and treatment of opiomania |
| abstract | FIELD: medicine, narcology. n SUBSTANCE: invention involves using immunogenic monoclonal antibodies raised to opiates as an agent used in prophylaxis and treatment and treatment of opiomania. Invention provides expanding assortment of pathogenetic agents used in treatment and prophylaxis of opiomania and enhancing effectiveness in treatment. Invention can be used in prophylaxis and treatment of opiomania. n EFFECT: enhanced and valuable properties of agent. n 2 cl, 1 tbl, 6 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2548802-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702002-C1 |
| priorityDate | 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.